Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes
Reproductive Biology · 2023
DOI: 10.1016/j.repbio.2023.100816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Biology, 2023. Verfasst von Shu-Wing Ng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA, USA; Mother Infant Research Institute, Tufts Medical Center, …. Hauptthemen laut MEDLINE: Ferroptosis, Premature Birth, Iron Overload. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Iron overload is associated with pregnancy complications. Ferroportin (FPN) is the only known iron exporter in mammalian cells. We hypothesize that FPN is functionally important in ferrotopsis, a process of iron-dependent non-apoptotic programmed cell death, and may have a critical role to play in pregnancy success. We investigated the expression of FPN in placenta/fetal membranes by immunohistochemistry in tissues collected from pregnancies with/without preeclampsia (PE) and spontaneous preterm birth (SPTB). FPN was highly expressed in both trophoblasts and decidual cells found in placenta/fetal membranes. Staining was significantly reduced in fetal membranes from SPTB versus healthy pregnancies (P = 0.046). FPN expression in immortalized human endometrial stromal cells (HESC) increased with in vitro decidualization induction using 1 μM of medroxyprogesterone acetate and 0.5 mM of dibutyryl-cAMP. In addition, both HESC cells and immortalized extravillous trophoblast SW71 cells with FPN knockdown showed significant sensitivity to ferroptosis inducer, erastin (P < 0.001 and P = 0.009, respectively). The survival of both HESC and SW71 cells was not negatively affected by iron supplementation with ferric ammonium citrate in the medium. However, SW71 cells were more sensitive than HESC cells to physiologic iron in the presence of a non-lethal dose of erastin (P < 0.001). Taken together, our data demonstrating increased sensitivity of FPN knockdown HESC and SW71 cells to erastin and increased sensitivity of trophoblasts to iron overload under ferroptotic stress support the hypothesis that FPN protects against ferroptosis during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA, USA; Mother Infant Research Institute, Tufts Medical Center, Boston, MA, USA. Electronic address: sng1@tuftsmedicalcenter.org.
- Department of Obstetrics & Gynecology, Tufts University School of Medicine, Boston, MA, USA; Mother Infant Research Institute, Tufts Medical Center, Boston, MA, USA.
- School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Nathan, Australia.
- Department of Molecular & Developmental Medicine, University of Siena, Siena, Italy.
- Newton-Wellesley Hospital, Newton, MA, USA. Electronic address: errolnorwitz@gmail.com.
Zitieren
APA
Ng, S. W., Lee, C., Ng, A., Ng, S. K., Arcuri, F., House, M. D., & Norwitz, E. R. (2023). Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes. Reproductive Biology. https://doi.org/10.1016/j.repbio.2023.100816
Vancouver
Ng SW, Lee C, Ng A, Ng SK, Arcuri F, House MD, et al. Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes. Reproductive Biology. 2023. doi:10.1016/j.repbio.2023.100816
BibTeX
@article{Ng2023,
author = {Ng, Shu-Wing and Lee, Chungyan and Ng, Allen and Ng, Shu-Kay and Arcuri, Felice and House, Michael D and Norwitz, Errol R},
title = {Ferroportin expression and regulation in human placenta/fetal membranes: Implications for ferroptosis and adverse pregnancy outcomes},
journal = {Reproductive Biology},
year = {2023},
doi = {10.1016/j.repbio.2023.100816}
}
EUVIMED